A Study Comparing Ceftazidime-Avibactam Versus Meropenem in Hospitalized Adults With Nosocomial Pneumonia

Clinical trial NCT01808092 · COMPLETED

Trial details

NCT number: NCT01808092
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Nosocomial Pneumonia (NP)Ventilator-associated Pneumonia (VAP)

Start date: 2013-04-01
Primary completion: 2016-01-01
Enrollment: 969

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.